N
CERE

Natixis’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Natixis’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-71,789
Closed -$2.94M – 1142
2024
Q2 		$2.94M Hold
71,789
– – 0.02% 347
2024
Q1 		$3.03M Sell
71,789
-48,906
-41% -$2.07M 0.02% 362
2023
Q4 		$5.12M Buy
+120,695
New +$5.12M 0.04% 275